Ibogaine

A powerful tool — that demands real medical care.

Ibogaine is a naturally occurring psychoactive compound derived from the West African iboga shrub (Tabernanthe iboga). In a supervised medical setting it produces a single, long (often 24–36 hour) introspective experience that, for many people, sharply reduces drug cravings and eases withdrawal — which is why it’s best known for interrupting opioid and other substance addictions.

It is not a casual or recreational experience, and it is not a cure-all. Ibogaine is not approved by the FDA and is a Schedule I substance in the United States; it is administered legally in supervised clinics in countries such as Mexico and Costa Rica. It is only appropriate under proper medical screening and supervision, which is where eligibility is actually decided. Research is still early but increasingly promising — including recent work in veterans with traumatic brain injury and PTSD — and we’ll always tell you honestly what is and isn’t established.

Most people who consider ibogaine have already tried everything else.

Honest note: ibogaine isn’t right for everyone, and part of our job is telling you when it isn’t — or isn’t yet. Appropriateness depends on your medical history, current medications, and cardiac health.

A careful, medically-supervised process.

With ibogaine, the provider is the safety.

Because the risks are managed by screening, monitoring, and staff, the single most important decision you make is where you go. That’s the whole reason we exist — and why we hold every ibogaine provider to a published, ten-point standard before we’d ever introduce you.

For the specific dependencies people most often ask about, see ibogaine for opioid addiction and ibogaine for methamphetamine addiction.

What happens afterwards matters as much as the session: the 90 days of integration that decide outcomes, and how long the effects actually last.

See the full PC Provider Standard™ → Get the Safe Provider Evaluation Guide →

What does ibogaine treatment cost, and how long does it take?

A complete programme runs $5,000 to $15,000 depending on length of stay and facility, plus travel. Most programmes run five to fourteen nights, built around a single dosing session of 24–36 hours.

The dose is one night. The programme around it is not. A five-night stay sits at the bottom of the range; ten nights prices around $12,500. What moves the number is length of stay, the facility, and how much medical staffing sits behind the session — which is exactly the thing you should not be shopping for on price. Flights, pre-travel bloodwork and an ECG sit on top. Our full breakdown of what a programme fee actually covers goes line by line.

Who is a candidate for ibogaine treatment?

Most people who come to us are opioid, kratom or 7-OH dependent, or carrying trauma that has not moved with conventional treatment. Eligibility is decided by the screening, not by us — and a good programme turns people away.

It is most often used for opioid and stimulant dependence, and for PTSD and the after-effects of traumatic brain injury — the population in the Stanford veterans research. It is not a fit for everyone: certain heart conditions, liver disease, active untreated psychosis and a number of common prescriptions rule people out, and several medications must be tapered and cleared before travel. That is what the pre-admission work-up is for, and a programme willing to skip it is telling you something. If you want the longer explanation first, our page on what ibogaine is and how it works covers the mechanism, and the safety guide goes through eligibility in full.

Ibogaine FAQ.

If you or someone you love is in crisis, call or text 988 (Suicide & Crisis Lifeline), or SAMHSA‘s National Helpline at 1-800-662-4357. This page is education and advocacy — not medical advice, diagnosis, or treatment. Ibogaine is not FDA-approved and carries real risks; always consult qualified medical professionals about your situation.